Clinicians must be vigilant in recognizing and managing severe neurologic complications, such as acute dystonic reaction and neuroleptic malignant syndrome, in patients receiving antipsychotic therapy.
No takes yet. Share an insight, caveat, or question.
Heightened monitoring for neurologic effects may be warranted with antipsychotics; leaves open precise incidence from prospective studies.
Suzanne White (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: